MCID: NNT012
MIFTS: 51

Neonatal Jaundice malady

Categories: Fetal diseases, Skin diseases

Aliases & Classifications for Neonatal Jaundice

About this section

Summaries for Neonatal Jaundice

About this section
Disease Ontology:11 A pigmentation disease characterized by a high level of bilirubin in the blood, causing a yellowing of the skin and other tissues of a newborn infant.

MalaCards based summary: Neonatal Jaundice, also known as hyperbilirubinemia, neonatal, is related to pyruvate kinase deficiency and bile acid synthesis defect, congenital, 4, and has symptoms including yellow complexion, neonatal hepatomegaly and hepatocellular jaundice. An important gene associated with Neonatal Jaundice is G6PD (Glucose-6-Phosphate Dehydrogenase), and among its related pathways are Codeine and Morphine Pathway, Pharmacokinetics and Drug Induction of Bile Acid Pathway. Affiliated tissues include skin, eye and liver, and related mouse phenotype homeostasis/metabolism.

Wikipedia:70 Neonatal jaundice or neonatal hyperbilirubinemia, or neonatal icterus (from the Greek word... more...

Related Diseases for Neonatal Jaundice

About this section

Diseases related to Neonatal Jaundice via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 98)
idRelated DiseaseScoreTop Affiliating Genes
1pyruvate kinase deficiency32.2G6PD, PKLR
2bile acid synthesis defect, congenital, 410.8
3sialuria10.8
4bile acid synthesis defect, congenital, 110.8
5cirrhosis, north american indian childhood type10.8
6hemolytic anemia due to g6pd deficiency10.8
7immunodeficiency 4710.8
8wernicke encephalopathy10.6G6PD, UGT1A1
9flucloxacilline toxicity10.5SLCO1B1, UGT1A1
10polyhydramnios10.4HMOX1, IL6
11acute hydrops keratoconus10.4SLCO1B1, UGT1A1
12leukostasis10.4G6PD, IL6
13pyeloureteritis cystica10.4SLCO1B1, UGT1A1
14larynx sarcoma10.3G6PD, PKLR, UGT1A1
15ulcerative stomatitis10.3G6PD, GSTM1
16auditory system disease10.2G6PD, SLCO1B1, UGT1A1
17hyperbilirubinemia, familial transient neonatal10.2
18skin amelanotic melanoma10.2HMOX1, HMOX2
19berylliosis10.1GSTM1, IL6
20kernicterus10.1
21corneal deposit10.1IL1B, IL6
22tarsal tunnel syndrome10.1IL1B, IL6
23scrotum paget's disease10.1IL1B, IL6
24midline interhemispheric variant of holoprosencephaly10.1IL1B, IL6
25hemoglobinopathy10.1IL1B, IL6
26melorheostosis10.1IL1B, IL6
27infancy electroclinical syndrome10.1IL1B, IL6
28hypothyroidism10.1IL1B, IL6
29autoimmune polyendocrine syndrome10.0IL1B, IL6
30skin disease10.0IL1B, IL6
31conventional leiomyosarcoma10.0IL1B, IL6
32scarlet fever10.0IL1B, IL6
33lung occult adenocarcinoma10.0IL1B, IL6
34non-secretory myeloma10.0IL1B, IL6
35qualitative platelet defect10.0IL1B, IL6
36inflammatory spondylopathy10.0IL1B, IL6
37sterility due to immotile flagella10.0IL1B, IL6
38syphilitic encephalitis10.0IL1B, IL6
39ocular cancer10.0IL1B, IL6
40orbital lymphangioma10.0IL1B, IL6
41periodic paralyses10.0IL1B, IL6
42paraneoplastic polyneuropathy10.0IL1B, IL6
43scn8a encephalopathy10.0IL1B, IL6
44human monocytic ehrlichiosis10.0IL1B, IL6
45philophthalmiasis10.0IL1B, IL6
46thoracic aortic aneurysm10.0IL1B, IL6
47ulcerative colitis10.0IL1B, IL6
48ampulla of vater neoplasm9.9IL1B, IL6
49oral candidiasis9.9IL1B, IL6
50foodborne botulism9.9IL1B, IL6

Graphical network of the top 20 diseases related to Neonatal Jaundice:



Diseases related to neonatal jaundice

Symptoms for Neonatal Jaundice

About this section

UMLS symptoms related to Neonatal Jaundice:


yellow complexion, neonatal hepatomegaly, hepatocellular jaundice, newborn physiological jaundice, neonatal jaundice due to excessive hemolysis, cushingoid facies

Drugs & Therapeutics for Neonatal Jaundice

About this section

Drugs for Neonatal Jaundice (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 107)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
ZincapprovedPhase 4, Phase 3, Phase 1, Phase 222317440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
2
Pyrimethamineapproved, vet_approvedPhase 415258-14-04993
Synonyms:
2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine
46706_FLUKA
46706_RIEDEL
4753 R.P.
4753 r.p
5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4-CHLORO-PHENYL)-6-ETHYL-PYRIMIDINE-2,4-DIAMINE
5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE
5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidi nediamine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine
5-(4-chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine
5-(p-chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-[4-Chlorophenyl]-6-ethyl-2,4-pyrimidinediamine
58-14-0
AB00052084
AC-7879
AC1L1JDI
AI3-25005
AZT + Pyrimethamine combination
Aventis Brand of Pyrimethamine
BIDD:GT0149
BIDD:PXR0173
BPBio1_000147
BRD-K88429204-001-05-4
BRN 0219864
BSPBio_000133
BSPBio_003282
BW 50-63
BW 5063
C07391
C12H13ClN4
CAS-58-14-0
CCRIS 546
CD
CHEBI:8673
CHEMBL36
CID4993
CP6
CPD000058714
CRL-8131 & Pyrimethamine
CRL-8142 & Pyrimethamine
Chloridin
Chloridine
Chloridyn
D00488
D011739
DB00205
Darachlor
Daraclor
Darapram
Daraprim
Daraprim (TN)
Daraprime
Daraprin
Diaminopyritamin
Disulone
DivK1c_000652
EINECS 200-364-2
EXR-101
Erbaprelina
Ethylpyrimidine
Fansidar
Fansidar (Pyrimethamine/Sulfadoxine)
Glaxo Wellcome Brand of Pyrimethamine
GlaxoSmithKline Brand of Pyrimethamine
HMS1568G15
HMS1920N12
HMS2092E13
HMS502A14
IDI1_000652
KBio1_000652
KBio2_001386
KBio2_003954
 
KBio2_006522
KBio3_002502
KBioGR_001007
KBioSS_001386
Khloridin
L000713
LS-238
Lactoferrin B & Pyrimethamine
Lactoferrin H & Pyrimethamine
MCB-3837
MLS000028606
MLS001148621
MLS002454446
MLS002701881
Malacid
Malocid
Malocide
Maloprim
MolPort-001-783-655
NCGC00016256-01
NCGC00016256-02
NCGC00023188-03
NCGC00023188-04
NCGC00023188-05
NCGC00023188-06
NCGC00023188-07
NCI-C01683
NCI60_002604
NCIOpen2_008313
NINDS_000652
NSC 3061
NSC-3061
NSC3061
Oxaquin
Pirimecidan
Pirimetamin
Pirimetamina
Pirimetamina [INN-Spanish]
Pirimetamina [Spanish]
Prestwick0_000037
Prestwick1_000037
Prestwick2_000037
Prestwick3_000037
Prestwick_504
Primethamine
Pyremethamine
Pyrimethamin
Pyrimethamine (JAN/USP/INN)
Pyrimethamine (Pyr)
Pyrimethamine Hcl
Pyrimethamine [USAN:INN:BAN:JAN]
Pyrimethaminum
Pyrimethaminum [INN-Latin]
RP 4753
S2006_Selleck
SAM002554921
SMR000058714
SPBio_000672
SPBio_002054
SPECTRUM1500520
Spectrum2_000886
Spectrum3_001701
Spectrum4_000494
Spectrum5_001447
Spectrum_000906
TCMDC-123831
TCMDC-125860
Tindurin
Tindurine
Tinduring
UNII-Z3614QOX8W
WLN: T6N CNJ BZ DZ ER DG& F2
WR 2978
Wellcome Brand of Pyrimethamine
ZINC00057464
m alocid
nchembio.215-comp13
nchembio.87-comp22
pyrimethamine
3
Oxytocinapproved, vet_approvedPhase 440850-56-6439302, 53477758
Synonyms:
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
(Arg8)-Vasopressin
(Arg8)-Vasotocin
1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide
50-56-6
AC1L9735
Argipressin
Argpressin Acetate
BCBcMAP01_000094
Biotinyl-(Arg8)-Vasopressin
C00746
CHEBI:492195
CHEBI:7872
CHEMBL395429
CID439302
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2
Cys-Tyr-Ile-Thr-Asn-Cys-Gly-Leu-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2
D00089
Disulfide bridge Cys1-Cys6
Gly-Leu-Pro-c
HS-2021
 
L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic(1-6)-disulfide
MolPort-003-938-941
NCGC00167132-01
O3251_SIGMA
O4375_SIGMA
OXT
OXYTOCIN
Ocytocin
Oxitocina
Oxytocic hormone
Oxytocin (JP15/USP/INN)
Oxytocin (TN)
Oxytocin 10 Usp Units In Dextrose 5%
Oxytocin 20 Usp Units In Dextrose 5%
Oxytocin 5 Usp Units In Dextrose 5%
Oxytocin Acetate
Oxytocin injection
Oxytocine
Oxytocinum
Pitocin
Pitocin (TN)
Syntocinon
Syntocinon (TN)
TI-001
alpha-Hypophamine
nchembio.184-comp2
4
GlyburideapprovedPhase 4, Phase 311110238-21-83488
Synonyms:
1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea
1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea
10238-21-8
5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide
5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide
5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide
AB00051949
AC1L1G1Q
AC1Q44V7
AKOS001487495
Abbenclamide
Adiab
Apo-Glibenclamide
Azuglucon
BIDD:GT0239
BPBio1_000344
BRD-K36927236-001-06-0
BRN 2230085
BSPBio_000312
BSPBio_001351
BSPBio_003053
Bastiverit
Benclamin
Betanase
Betanese 5
Bio-0156
Bio1_000076
Bio1_000565
Bio1_001054
Bio2_000071
Bio2_000551
C07022
C23H28ClN3O5S
CAS-10238-21-8
CBiol_001790
CHEBI:5441
CHEMBL472
CID3488
CPD000058229
Calabren
Cytagon
D00336
D005905
DB01016
Daonil
Debtan
Dia-basan
Diabeta
Diabeta (TN)
Diabiphage
Dibelet
DivK1c_000481
Duraglucon
EINECS 233-570-6
EU-0100499
Euclamin
Euglucan
Euglucon
Euglucon 5
Euglucon N
Euglykon
G 0639
G0639_SIAL
G0639_SIGMA
G2539_SIAL
GBN 5
Gen-Glybe
Gewaglucon
Gilemal
Glamide
Glibadone
Gliban
Gliben
Gliben-Puren N
Glibenbeta
Glibenclamid AL
Glibenclamid Basics
Glibenclamid Fabra
Glibenclamid Genericon
Glibenclamid Heumann
Glibenclamid Riker M
Glibenclamid Riker M.
Glibenclamid-Cophar
Glibenclamid-Ratiopharm
Glibenclamida
Glibenclamida [INN-Spanish]
Glibenclamide
Glibenclamide (JP15/INN)
Glibenclamidum
Glibenclamidum [INN-Latin]
Glibenil
Glibens
Glibesyn
Glibet
Glibetic
Glibil
Gliboral
Glicem
Glidiabet
Glimel
Glimide
Glimidstata
Glisulin
Glitisol
Glubate
Gluben
Gluco-Tablimen
Glucobene
Glucohexal
Glucolon
Glucomid
Glucoremed
Glucoven
Glyben
Glybenclamide
Glybenzcyclamide
Glyburide
Glyburide (USP)
Glyburide (micronized)
Glyburide [USAN]
 
Glycolande
Glycomin
Glynase
Glynase (TN)
HB 419
HB 420
HB-419
HB-420
HB419
HB420
HMS1361D13
HMS1568P14
HMS1791D13
HMS1922L08
HMS1989D13
HMS2089L06
HMS2093P04
HMS501I03
Hemi-Daonil
Hexaglucon
Humedia
I06-0716
IDI1_000481
IDI1_033821
KBio1_000481
KBio2_000071
KBio2_000730
KBio2_002639
KBio2_003298
KBio2_005207
KBio2_005866
KBio3_000141
KBio3_000142
KBio3_002273
KBioGR_000071
KBioGR_001897
KBioSS_000071
KBioSS_000730
LS-159295
Lederglib
Libanil
Lisaglucon
Lopac-G-0639
Lopac0_000499
MLS000069721
MLS001077262
Malix
Maninil
Med-Glionil
Melix
Micronase
Micronase (TN)
Micronized glyburide
Miglucan
MolPort-000-784-850
N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea
N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N -cyclohexylurea
N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea
NCGC00015467-01
NCGC00015467-02
NCGC00015467-06
NCGC00015467-16
NCGC00016689-01
NCGC00023447-02
NCGC00023447-04
NCGC00023447-05
NCGC00023447-06
NCGC00023447-07
NCGC00023447-08
NCGC00023447-09
NCGC00023447-10
NCGC00023447-11
NCGC00023447-12
NINDS_000481
Nadib
Neogluconin
Norglicem 5
Normoglucon
Novo-Glyburide
Oprea1_764617
Orabetic
Pira
Praeciglucon
PresTab
Prestwick0_000316
Prestwick1_000316
Prestwick2_000316
Prestwick3_000316
Prestwick_569
Probes1_000431
Probes2_000378
Prodiabet
Renabetic
S1716_Selleck
SAM002564212
SMR000058229
SPBio_001831
SPBio_002531
SPECTRUM2300229
SR-01000000196-5
STK362992
Semi-Daonil
Semi-Euglucon
Semi-Gliben-Puren N
Semi-daonil
Spectrum2_001816
Spectrum3_001327
Spectrum4_001199
Spectrum5_001631
Spectrum_000250
Sugril
Suraben
Tiabet
Tocris-0911
U 26452
U-26452
UNII-SX6K58TVWC
UPCMLD-DP006
UPCMLD-DP006:001
UR 606
Yuglucon
ZINC00537805
glibenclamide
glyburide
5
MetforminapprovedPhase 4, Phase 2, Phase 31746657-24-914219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMGG
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
6
SulfadoxineapprovedPhase 41282447-57-617134
Synonyms:
2447-57-6
4-Amino-N-(5,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide
4-Sulfanilamido-5,6-dimethoxypyrimidine
4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide
4-amino-N-[5,6-bis(methyloxy)pyrimidin-4-yl]benzenesulfonamide
46810_RIEDEL
5-25-13-00306 (Beilstein Handbook Reference)
6-(4-Aminobenzenesulfonamido)-4,5-dimethoxypyrimidine
AB00514044
AC-11921
AC1L29DT
AC1Q46GG
Ambap2447-57-6
BPBio1_001286
BRD-K55250441-001-03-1
BRN 0625453
BSPBio_001168
C07630
CAS-2447-57-6
CHEBI:9329
CHEMBL1539
CID17134
D00580
DB01299
EINECS 219-504-9
Fanasil
Fanzil
HMS1571K10
HMS2090P07
HMS2094C19
I09-0529
LS-31247
MLS002154150
MolPort-003-850-341
N'-(5,6-Dimethoxy-4-pyrimidyl)sulfanilamide
N(sup 1)-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide
 
N1-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide
NCGC00016612-01
NCGC00016612-02
Orthosulfin
Prestwick0_001094
Prestwick1_001094
Prestwick2_001094
Prestwick3_001094
Ro 4-4393
Ro-4-4393
S2511_Selleck
S7821_SIGMA
SMR000857259
SPBio_003054
SULFADOXINE
Sanasil: Sulfadoxine: Sulformetoxin
Solfadossina
Solfadossina [DCIT]
Sulfadoxin
Sulfadoxina
Sulfadoxina [INN-Spanish]
Sulfadoxine
Sulfadoxine (JAN/USP/INN)
Sulfadoxine [USAN:INN:BAN:JAN]
Sulfadoxinum
Sulfadoxinum [INN-Latin]
Sulformethoxine
Sulformetoxine
Sulforthomidine
Sulphadoxine
Sulphormethoxine
Sulphormetoxin
Sulphorthodimethoxine
UNII-88463U4SM5
WR 4073
WR 4873
ZINC00002094
7
Insulin LisproapprovedPhase 4235133107-64-9
Synonyms:
Insulin lispro (genetical recombination)
Insulin lispro (rDNA origin)
Insulin lispro protamine
 
Insulin lispro protamine recombinant
Insulin lispro recombinant
Insulin,lispro,human/rDNA
Insulin,lispro,protamine/rDNA
8
LevoleucovorinapprovedPhase 471168538-85-2
Synonyms:
(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid
(6S)-5-formyltetrahydrofolic acid
(6S)-Folinic acid
(6S)-Leucovorin
 
(S)-Leucovorin
Citrovorum factor
L-Folinic acid
Levofolene
Levofolinic acid
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid
9
leucovorinapprovedPhase 4108958-05-9143, 54575
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formyltetrahydrofolic acid
Acide folinique
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
Folinate
Folinic acid
Folinic acid calcium salt
 
Folinic acid calcium salt USP27
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
L-Leucovorin
L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid
L-leucovorin
Leucal
Leucovorin calcium
Leucovorin folinic acid
Leucovorinum
Leukovorin
Levoleucovorin
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Welcovorin
Wellcovorin
folinate
10
SpiramycinapprovedPhase 4424916-50-5
Synonyms:
Demycarosylturimycin H
Foromacidine A
 
Spiramycin 1
Spiramycin A
foromacidin A
11
Sulfadiazineapproved, vet_approvedPhase 43268-35-95215
Synonyms:
141582-64-1
2-Sulfanilamido-pyrimidine
2-Sulfanilamidopyrimidin
2-Sulfanilamidopyrimidin [German]
2-Sulfanilamidopyrimidine
2-Sulfanilylaminopyrimidine
2-Sulfapyrimidine
2-sulfanilamidopyrimidine
2-sulfanilylaminopyrimidine
35033_FLUKA
35033_RIEDEL
4-AMINO-N-2-PYRIMIDINYLBENZENESULFONAMIDE
4-Amino-N-(2-pyrimidinyl)benzenesulfonamide
4-Amino-N-2-pyrimidinyl- benzenesulfonamide
4-Amino-N-2-pyrimidinyl-benzenesulfonamide
4-amino-N-(pyrimidin-2-yl)benzenesulfonamide
4-amino-N-2-pyrimidinylbenzenesulfonamide
4-amino-N-pyrimidin-2-ylbenzenesulfonamide
5-25-10-00067 (Beilstein Handbook Reference)
68-35-9
A 306
A-306
A-306 (VAN)
AB00052095
AC-12001
AC1L1JUR
AC1Q51XM
AC1Q6W1E
AI3-01047
AKOS000119073
AR-1L4215
Adiazin
Adiazin, Adiazine, Debenal, Liquadiazine, Microsulfon, Sulfazine, Sulfolex, Sulfadiazine
Adiazine
BB_SC-0628
BPBio1_000095
BRD-K32273377-001-05-4
BRN 0235192
BSPBio_000085
BSPBio_002884
C07658
C10H10N4O2S
CAS-68-35-9
CHEBI:9328
CHEMBL439
CID5215
CRL-8131 & Sulfadiazine
Coco-Diazine
CocoDiazine
Cocodiazine
Codiazine
Cremodiazine
Cremotres
D00587
D013411
DB00359
Debenal
Deltazina
Di-Azo-Mul
Diazin
Diazolone
Diazovit
Diazyl
DivK1c_000543
EINECS 200-685-8
Eskadiazine
HMS1568E07
HMS1921A13
HMS2090P09
HMS2092I15
HMS501L05
Honey Diazine
Honey diazine
IDI1_000543
KBio1_000543
KBio2_001466
KBio2_004034
KBio2_006602
KBio3_002104
KBioGR_000743
KBioSS_001466
LS-147838
Lantrisul
Lipo-Diazine
Lipo-Levazine
Liquadiazine
MLS000069423
Metha-Meridiazine
Microsulfon
Mixture of sulfadiazine, sulfamerazine, and sulfamethazine
MolPort-000-629-738
N(1)-2-Pyrimidinylsulfanilamide
N(1)-2-Pyrimidylsulfanilamide
N(1)-2-pyrimidinylsulfanilamide
N(1)-2-pyrimidylsulfanilamide
N(sup 1)-2-Pyrimidinylsulfanilamide
N(sup1)-2-Pyrimidinylsulfanilamide
N(sup1)-2-Pyrimidylsulfanilamide
N-(2-Pyrimidinyl)sulfanilamide
 
N1-(Pyrimidin-2-yl)sulfanilamide
N1-2-pyrimidinylsulfanilamide
N1-2-pyrimidylsulfanilamide
NCGC00016305-01
NCGC00016305-02
NCGC00023291-03
NCGC00023291-04
NINDS_000543
NSC 35600
NSC117870
NSC35600
Neazine
Neotrizine
Oprea1_081078
Palatrize
Pecta-Diazine
Pecta-diazine, suspension
Piridisir
Pirimal
Prestwick0_000023
Prestwick1_000023
Prestwick2_000023
Prestwick3_000023
Prestwick_428
Pyrimal
Quadetts
Quadramoid
RP 2616
Recombinant bactericidal/permeability-increasing protein & Sulfadiazine
S. N. 112
S.N. 112
S0579
S1770_Selleck
S8626_SIGMA
SDA
SMR000059113
SPBio_001417
SPBio_002006
SPECTRUM1500546
SSD
STK317797
Sanodiazine
Sildaflo
Silvadene
Solfadiazina
Solfadiazina [DCIT]
Spectrum2_001319
Spectrum3_001362
Spectrum4_000342
Spectrum5_000992
Spectrum_000986
Spofadrizine
Sterazine
Sulfa-Triple #2
Sulfacombin
Sulfadiazene
Sulfadiazin
Sulfadiazina
Sulfadiazina [INN-Spanish]
Sulfadiazine
Sulfadiazine (JAN/USP/INN)
Sulfadiazine (TN)
Sulfadiazine [USAN:INN:JAN]
Sulfadiazine, Zinc
Sulfadiazinum
Sulfadiazinum [INN-Latin]
Sulfaloid
Sulfanilamide, N1-2-pyrimidinyl- (8CI)
Sulfanilamidopyrimidine
Sulfapirimidin
Sulfapyrimidin
Sulfapyrimidin [German]
Sulfapyrimidine
Sulfatryl
Sulfazine
Sulfolex
Sulfonamides Duplex
Sulfonsol
Sulfose
Sulphadiazine
Sulphadiazine E
TL80073596
Terfonyl
Theradiazine
Thermazene
Thi-Di-Mer
Tri-Sulfameth
Trifonamide
Triple Sulfa
Triple Sulfas
Triple Sulfoid
Trisem
Trisulfapyrimidine, oral suspension
Truozine
UNII-0N7609K889
WLN: T6N CNJ BMSWR DZ
ZINC00120319
Zinc Sulfadiazine
rBPI21 & Sulfa
sulfadiazine
12
Folic Acidapproved, nutraceutical, vet_approvedPhase 4427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
13Vitamin B ComplexPhase 44229
14Protective AgentsPhase 4, Phase 3, Phase 1, Phase 27190
15insulinPhase 4, Phase 3, Phase 24524
16MicronutrientsPhase 4, Phase 1, Phase 25802
17
BilirubinPhase 4, Phase 3, Phase 1, Phase 2112635-65-45280352
Synonyms:
(4Z,15Z)-Bilirubin IXa
(Z,Z)-Bilirubin IXa
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionic acid
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoate
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
 
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
Bilirubin
Bilirubin IX-alpha
Cholerythrin
Hematoidin
18VitaminsPhase 45095
19Trace ElementsPhase 4, Phase 1, Phase 25802
20AntioxidantsPhase 4, Phase 3, Phase 1, Phase 22928
21Insulin, Globin ZincPhase 4, Phase 3, Phase 24523
22Immunoglobulins, IntravenousPhase 4, Phase 3324
23ProtaminesPhase 4179
24Pharmaceutical SolutionsPhase 4, Phase 27793
25Insulin, Short-ActingPhase 490
26Liver ExtractsPhase 4, Phase 1, Phase 23868
27Insulin, IsophanePhase 4252
28AntibodiesPhase 4, Phase 36045
29Antiparasitic AgentsPhase 42127
30Anti-Bacterial AgentsPhase 4, Early Phase 110884
31gamma-GlobulinsPhase 4, Phase 3317
32Rho(D) Immune GlobulinPhase 4, Phase 3317
33AntimalarialsPhase 41216
34Isophane insulin, beefPhase 4151
35Fanasil, pyrimethamine drug combinationPhase 4120
36Antiprotozoal AgentsPhase 41986
37Folic Acid AntagonistsPhase 42200
38Hypoglycemic AgentsPhase 4, Phase 2, Phase 35733
39Isophane Insulin, HumanPhase 4151
40Renal AgentsPhase 4732
41Anti-Infective AgentsPhase 4, Early Phase 121402
42ImmunoglobulinsPhase 4, Phase 36045
43AntidotesPhase 41038
44OxytocicsPhase 4660
45Calcium, DietaryPhase 45525
46Bone Density Conservation AgentsPhase 43266
47Folinic AcidNutraceuticalPhase 43150
48Vitamin B9NutraceuticalPhase 44279
49FolateNutraceuticalPhase 44279
50Omega 3 Fatty AcidNutraceuticalPhase 4, Phase 1, Phase 2969

Interventional clinical trials:

(show top 50)    (show all 109)
idNameStatusNCT IDPhase
1Use of a New Phototherapy Device (BBloo®) for the Treatment of Hyperbilirubinemia in the Newborn InfantUnknown statusNCT02156050Phase 4
2Reverse Phototherapy With Super Light-emitting Diode(Super-LED) for Hyperbilirubinemia in Term and Late Preterm InfantsUnknown statusNCT01340339Phase 4
3Metformin Versus Insulin in Gestational DiabetesCompletedNCT01240785Phase 4
4Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic DiseaseCompletedNCT00288600Phase 4
5Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in ZambiaCompletedNCT00270530Phase 4
6Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase DeficiencyRecruitingNCT02594904Phase 4
7Continued Versus Discontinued Oxytocin Stimulation of LabourRecruitingNCT02553226Phase 4
8Preventing Recurrent Gestational Diabetes With MetforminRecruitingNCT02394158Phase 4
9Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver DiseaseRecruitingNCT00862446Phase 4
10Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital ToxoplasmosisRecruitingNCT00004317Phase 4
11The Effect of Intravenous Oxytocin Infusion Using Different Diluents on Neonatal Bilirubin & Sodium LevelsActive, not recruitingNCT02602301Phase 4
12Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational DiabetesWithdrawnNCT00160485Phase 4
13Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth WeightCompletedNCT00114543Phase 3
14Transcutaneous Bilirubinometry in Healthy Term and Near-Term NeonatesCompletedNCT00653874Phase 3
15Efficacy and Safety of Stannsoporfin in NeonatesCompletedNCT02685137Phase 3
16Improving Health Outcomes for New Mothers and BabiesCompletedNCT00360204Phase 3
17Metformin in Obese Non-diabetic Pregnant WomenCompletedNCT01273584Phase 2, Phase 3
18Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled TrialCompletedNCT01222247Phase 3
19a Randomized Multicenter Trial Comparing Vacuum Assisted Delivery With the New Device "iCUP" Versus the Reference Cup.CompletedNCT01058200Phase 3
20Prospective Randomized Clinical Trial of Intravenous Lipids and CholestasisRecruitingNCT01555957Phase 3
21Metformin in Women With Type 2 Diabetes in Pregnancy TrialRecruitingNCT01353391Phase 3
22Modulation of the Intestinal Flora With the Probiotic VIVOMIXX™ in Pregnant Women at Risk of Metabolic ComplicationsRecruitingNCT02768818Phase 3
23A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)RecruitingNCT01376778Phase 3
24Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Patients With Cerebral ParalysisRecruitingNCT01929434Phase 3
25Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational DiabetesActive, not recruitingNCT01731431Phase 3
26Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)Not yet recruitingNCT02932475Phase 3
27Filtered Sunlight Phototherapy to Treat Significant Jaundice: Safety and Efficacy in NeonatesCompletedNCT02612727Phase 1, Phase 2
28Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates With HyperbilirubinemiaCompletedNCT01887327Phase 2
29Treatment of Neonatal Jaundice With Filtered Sunlight Phototherapy: Safety and Efficacy in African NeonatesCompletedNCT01434810Phase 1, Phase 2
30Follow-up, Blinded-Outcomes Trial of Subjects Having Received IMP in Clinical Trial 64,185-202CompletedNCT02033096Phase 2
31Phase II Randomized Study of Tin Mesoporphyrin for Neonatal HyperbilirubinemiaCompletedNCT00004381Phase 2
32Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized TrialCompletedNCT00692224Phase 1, Phase 2
33Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature NewbornsCompletedNCT00004382Phase 2
34Safety and Pharmacology of StanateCompletedNCT00115544Phase 2
35Effect of Timing of Umbilical Cord Clamping on Haematological and Clinical Outcomes of InfantsCompletedNCT01081977Phase 2
36SMOFlipid to Lessen the Severity of Neonatal CholestasisCompletedNCT02721277Phase 1, Phase 2
37Early Screening and Treatment of Women With Prediabetes in PregnancyActive, not recruitingNCT01552213Phase 2
38A Safety and Efficacy Trial of Stannsoporfin in Neonates With HyperbilirubinemiaTerminatedNCT00850993Phase 2
39Effect of Early Limited Formula on Total Serum Bilirubin Among Newborns With HyperbilirubinemiaUnknown statusNCT01330667
40Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.Unknown statusNCT00154960
41Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of HemolysisUnknown statusNCT00917007
42Resting State Functional Magnetic Resonance Imaging Study of Jaundice Infants Before and After Light Treatment.Unknown statusNCT02224586
43New Phototherapy Device to Treat Patients With Crigler-Najjar DiseaseUnknown statusNCT02356978
44NPD Measurements in PSC PatientsUnknown statusNCT00476814
45Healthy Moms, Healthy BabiesUnknown statusNCT01578460
46Inositol Stereoisomers to Treat Gestational DiabetesUnknown statusNCT02097069
47The Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese InfantsCompletedNCT01762189
48Prediction of Neonatal HyperbilirubinemiaCompletedNCT01109277
49The Predictors of the Neonatal HyperbilirubinemiaCompletedNCT00154999
50Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm InfantsCompletedNCT01763632

Search NIH Clinical Center for Neonatal Jaundice


Cochrane evidence based reviews: jaundice, neonatal

Genetic Tests for Neonatal Jaundice

About this section

Anatomical Context for Neonatal Jaundice

About this section

MalaCards organs/tissues related to Neonatal Jaundice:

35
Skin, Eye, Liver, Bone, Brain, Colon

Animal Models for Neonatal Jaundice or affiliated genes

About this section

MGI Mouse Phenotypes related to Neonatal Jaundice:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053766.7G6PD, HMOX1, HMOX2, IL1B, IL6, NR1I3

Publications for Neonatal Jaundice

About this section

Articles related to Neonatal Jaundice:

(show top 50)    (show all 566)
idTitleAuthorsYear
1
Yinzhihuang oral liquid in the treatment of neonatal jaundice: a meta-analysis. (27937684)
2017
2
Kernicterus in Neonatal Jaundice-Finding the Needle in the Haystack. (26945202)
2016
3
50 Years Ago in The Journal of Pediatrics: Studies of Prolonged Neonatal Jaundice in the Breast-Fed Infant. (26719182)
2016
4
Care practices and traditional beliefs related to neonatal jaundice in northern Vietnam: a population-based, cross-sectional descriptive study. (25316215)
2014
5
Neonatal jaundice and increased risk of attention-deficit hyperactivity disorder: a population-based cohort study. (25056274)
2014
6
Liver disease in children: from neonatal jaundice to living donor liver transplantation. (26038791)
2014
7
Evaluation of maternal knowledge level about neonatal jaundice. (22082141)
2012
8
The side effects of phototherapy for neonatal jaundice: what do we know? What should we do? (21455834)
2011
9
Bilirubin rebound after intensive phototherapy for neonatal jaundice. (20019393)
2010
10
Twists and turns in phototherapy for neonatal jaundice. (20528792)
2010
11
Maternal experience with neonatal jaundice. (20032753)
2010
12
Prolonged neonatal jaundice and the diagnosis of biliary atresia: a single-center analysis of trends in age at diagnosis and outcomes. (18443020)
2008
13
Are glutathione S-transferase gene polymorphisms linked to neonatal jaundice? (17318621)
2008
14
Understanding neonatal jaundice: UK practice and international profile. (18678117)
2008
15
Role of genetic factors in occurrence of neonatal jaundice in Guangxi region]. (16255851)
2005
16
Neonatal jaundice. (15652016)
2004
17
Immunizations, neonatal jaundice, and animal-induced injuries. (15273509)
2004
18
Breast-feeding, neonatal jaundice and kernicterus. (12208098)
2002
19
Pharmacological interventions for the treatment of neonatal jaundice. (12208095)
2002
20
System-based approach to management of neonatal jaundice and prevention of kernicterus. (12006952)
2002
21
Spectrum of outcome in infants with extreme neonatal jaundice. (11519982)
2001
22
Rehospitalisation for neonatal jaundice: risk factors and outcomes. (11703683)
2001
23
Neonatal jaundice, animal-based injuries, and immunizations. (9757374)
1998
24
Comparison technetium of Tc-99m disofenin cholescintigraphy with ultrasonography in the differentiation of biliary atresia from other forms of neonatal jaundice. (9035206)
1997
25
Can severe neonatal jaundice be prevented by neonatal screening for glucose-6-phosphate dehydrogenase deficiency?--a review of evidence. (8942026)
1996
26
Neonatal jaundice, aflatoxins and naphthols: report of a study in Ibadan, Nigeria. (7677410)
1995
27
Etiology of neonatal jaundice at Shimla. (7875794)
1994
28
Animal-induced injuries and disease, viral infections, neonatal jaundice, and immunizations. (7951675)
1994
29
Animal-induced injuries and disease, neonatal jaundice, viral infections, and immunizations. (8374681)
1993
30
Neonatal jaundice: update on phototherapy management. (8363337)
1993
31
Treating neonatal jaundice with phenobarbitone: the inadvertant administration of significant doses of ethyl alcohol. (1739339)
1992
32
Value of bile acid determination for the diagnosis of neonatal jaundice. (2102973)
1990
33
Management of neonatal jaundice. (2683113)
1989
34
Neonatal jaundice. (3281408)
1988
35
123I BSP scanning in neonatal jaundice. (3566138)
1986
36
Neonatal jaundice: its prevalence in Chinese babies and associating factors. (3767789)
1986
37
Neonatal jaundice among full term infants in Riyadh: a prospective study of 190 hospital admissions. (4092624)
1985
38
Bupivacaine alters red blood cell properties: a possible explanation for neonatal jaundice associated with maternal anesthesia. (4000759)
1985
39
Blood brain barrier in neonatal jaundice. (3843560)
1985
40
Enzymatic removal of bilirubin from blood: a potential treatment for neonatal jaundice. (4048947)
1985
41
Chemoprevention of neonatal jaundice: potency of tin-protoporphyrin in an animal model. (6896768)
1982
42
The use of diethyl-IDA Tc 99m clearance curves in the differentiation of biliary atresia from other forms of neonatal jaundice. (7063701)
1982
43
Neonatal jaundice in twins. (7190005)
1980
44
Factors influencing the incidence of neonatal jaundice. (647211)
1978
45
Red cell metabolism and severe neonatal jaundice in West Malaysia. (409030)
1977
46
Red cell potassium levels in neonatal jaundice --a preliminary study. (859375)
1977
47
Phototherapy for neonatal jaundice in rural Africa. (841688)
1977
48
Oxytocin and neonatal jaundice. (974702)
1976
49
Letter: Neonatal jaundice in association with operative delivery. (943205)
1976
50
Cytomegalic inclusion disease: another cause for neonatal jaundice. (13611436)
1959

Variations for Neonatal Jaundice

About this section

Expression for genes affiliated with Neonatal Jaundice

About this section
Search GEO for disease gene expression data for Neonatal Jaundice.

Pathways for genes affiliated with Neonatal Jaundice

About this section

GO Terms for genes affiliated with Neonatal Jaundice

About this section

Biological processes related to Neonatal Jaundice according to GeneCards Suite gene sharing:

(show all 16)
idNameGO IDScoreTop Affiliating Genes
1heme oxidationGO:000678810.4HMOX1, HMOX2
2positive regulation of chemokine biosynthetic processGO:004508010.2HMOX1, IL1B
3cellular response to estradiol stimulusGO:007139210.0IL6, UGT1A1
4regulation of angiogenesisGO:004576510.0HMOX1, IL6
5heme catabolic processGO:004216710.0HMOX1, HMOX2, UGT1A1
6estrogen metabolic processGO:00082109.9IL1B, UGT1A1
7positive regulation of prostaglandin secretionGO:00323089.8IL1B, OXT
8response to foodGO:00320949.7G6PD, OXT
9response to ATPGO:00331989.6IL1B, PKLR
10response to lipopolysaccharideGO:00324969.4IL1B, IL6, UGT1A1
11response to electrical stimulusGO:00516029.4IL6, OXT
12response to ethanolGO:00454719.4G6PD, IL1B, UGT1A1
13response to glucocorticoidGO:00513849.3IL6, OXT, UGT1A1
14response to heatGO:00094089.2IL1B, IL6, PKLR
15response to hypoxiaGO:00016668.5HMOX1, HMOX2, IL1B, PKLR
16response to organic cyclic compoundGO:00140708.5G6PD, IL6, OXT, PKLR, UGT1A1

Molecular functions related to Neonatal Jaundice according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1heme oxygenase (decyclizing) activityGO:00043929.7HMOX1, HMOX2

Sources for Neonatal Jaundice

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet